Now showing items 1-4 of 4
Recruiting subjects in cancer prevention and control studies
(John Wiley & Sons, Inc., 2000)
Recruitment of subjects is a critical aspect of prevention trials that is often overlooked by investigators. As a consequence, accrual time is often extended, workloads may become heavy, and resource utilization is increased ...
Surrogate endpoint biomarkers for cervical cancer chemoprevention trials
(Wiley Subscription Services, Inc., A Wiley Company, 1995)
Cervical intraepithelia neoplasia (CIN) represents a spectrum of epithelial changes that provide an excellent model for developing chemopreventive interventions for cervical cancer. Possible drug effect surrogate endpoint ...
Selection criteria for breast cancer chemoprevention subjects
(Wiley Subscription Services, Inc., A Wiley Company, 1993)
Early phase chemoprevention trials differ from standard therapeutic clinical trials because asymptomatic, healthy people are treated with a potentially toxic intervention for a prolonged period of time. Current subject ...
How men view genetic testing for prostate cancer risk: findings from focus groups
(Munksgaard International PublishersBlackwell Publishing Ltd, 2000-09)